CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 71 enrolled
Drug / intervention
Intrapersonal Stigma Reduction +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04693416
NCT04693416Phase 2Completed

SMART Trial: Reducing Stigma Towards Opioid Use Disorder on the Intrapersonal and Interpersonal Levels

University of Tennessee·interventional·Posted Jan 5, 2021·Updated Mar 9, 2023

In Brief

A Phase 2 clinical trial evaluating Intrapersonal Stigma Reduction and Interpersonal Stigma Reduction for Stigma, Social and 3 related conditions. Completed, enrolled 71 participants across 1 site.

Detailed Summary

The goal of this project is to develop a multicomponent stigma reduction intervention to address intrapersonal (individual) stigma regarding Opioid Use Disorder (OUD). The intervention will address this cost/benefit evaluation among individuals known to face intersecting stigma of OUD and African American race, with treatment elements chosen explicitly to increase the value of treatment using salient forms of reward, and to ease perceived costs through explicit services in an effort to encourage the occurrence of the first treatment visit for OUD.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

Phase 2CompletedFinished
202120222023202420252026
First PostedJan 5, 2021
Enrollment StartMar 8, 2021
Primary CompletionAug 30, 2021
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 5.5 years ago

Interventions

Intrapersonal Stigma Reductionother

Brief intervention for stigma reduction

Interpersonal Stigma Reductionother

Brief intervention for support persons of intrapersonal intervention participants.